Mineralocorticoid Blocker Gets EU Nod for Heart Failure

Kerendia may soon be authorized in the EU for heart failure and an ejection fraction of 40% or higher.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/mineralocorticoid-blocker-gets-eu-nod-heart-failure-2026a10003cs?src=rss

Author :

Publish date : 2026-02-03 12:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Mineralocorticoid Blocker Gets EU Nod for Heart Failure

Pneumonia Admissions Climb as Charity Flags Care Gaps

CGRPs for Migraine Tied to ‘Modest’ Heart Risk

Related Posts

Dialysis Accessibility; Accountable Care Organizations and Medicare Savings

Living After Suicidality: A Physician’s Framework for Healing

People Are Chilling Their Carbs to Try to Lose Weight

Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

Novel Two-Drug Combo Equals Standard Triplet in Untreated Patients With HIV

Not All Cardiovascular Disease Risks Start in the Heart. Here’s Why

Dialysis Accessibility; Accountable Care Organizations and Medicare Savings

Living After Suicidality: A Physician’s Framework for Healing

People Are Chilling Their Carbs to Try to Lose Weight

Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

Novel Two-Drug Combo Equals Standard Triplet in Untreated Patients With HIV

Not All Cardiovascular Disease Risks Start in the Heart. Here’s Why

I take 120 tablets a week after mesh operation

I woke up from an operation in agony and the pain never went away

Categories

Archives